The Newsroom
Item 1 of 3
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
Item 2 of 3
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Item 3 of 3
Mayor Demings, AdventHealth on bridging health care gaps
Recent Stories at AdventHealthMD
-
-
AdventHealth First in Florida to Successfully Implant Thoraflex™ Hybrid Device in Patient with Complex Aortic Arch Dissection
-
AdventHealth Chief Science Officer receives national award related to obesity research
-
AdventHealth for Children Performs Florida’s First Alterra Adaptive Prestent and Valve Implant on a Patient with Congenital Heart Disease
-
AdventHealth Among First in the U.S. to Use New MITRIS RESILIA Bioprosthetic Mitral Replacement Valve with Anti-calcification Technology
-
How AdventHealth Mission Control drives improved emergency department outcomes
-
AdventHealth physician and team develop a new test to quickly detect brain-eating amoebas
-
AdventHealth leader testifies to U.S. Senate, surgeon agrees organ transplant system has failed
-
Hepatic Arterial Infusion Pump Offers New Hope to Patients with Liver Metastases from Colorectal and Bile Duct Cancers